Cue Biopharma, Inc.
Pharmaceutical Preparations · Boston, MA, United States
- PrincipalsDaniel G. BakerCHIEF DEVELOPMENT OFFICERLucinda WarrenCHIEF BUSINESS OFFICERUsman AzamCHIEF EXECUTIVE OFFICERand 7 more
- CompanyCue Biopharma, Inc.Boston, MA, United States
- Phone line+1 (617) 949-2680General business
Cue Biopharma, Inc. is an SEC-registered Nasdaq-listed company (ticker CUE) classified under SIC 2834: Pharmaceutical Preparations.
Capabilities
✓ Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions
People 10
Chief executive
Usman AzamCHIEF EXECUTIVE OFFICER
Chair & board
Frank MorichDirector (Board)
Jill Marie BroadfootDirector (Board)
Pamela GarzoneDirector (Board)
Pasha SarrafDirector (Board)
Legal
Colin SandercockSVP, GENERAL COUNSEL
Everyone else on file (2)
Daniel G. BakerCHIEF DEVELOPMENT OFFICER
Lucinda WarrenCHIEF BUSINESS OFFICER
Supplier profile
- Production
- Yes
Source timeline
Record created from SEC EDGAR company submissions
SEC EDGAR company submissions ↗Daniel G. Baker — CHIEF DEVELOPMENT OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Lucinda Warren — CHIEF BUSINESS OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Usman Azam — CHIEF EXECUTIVE OFFICER
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗Colin Sandercock — SVP, GENERAL COUNSEL
SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
Similar makers
InMed Pharmaceuticals Inc.Pharmaceutical Preparations · Vancouver1 shared capabilityuniQure N.V.Pharmaceutical Preparations · Amsterdam1 shared capabilityChemomab Therapeutics Ltd.Pharmaceutical Preparations · Tel Aviv1 shared capabilityCannapharmarx, Inc.Pharmaceutical Preparations · Mountain View County1 shared capabilityQuantum Cyber N.V.Pharmaceutical Preparations · Mainz1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityEdesa Biotech, Inc.Pharmaceutical Preparations · Markham1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capability